| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 51 | 41 | 57 | 48 | 54 | 45 | 66 | 58 | 65 | 52 | 56 | 54 | 58 | 54 | 54 | 49 | 45 | 44 | 35 | 52 | 65 | 63 | 72 | 71 | 68 | 70 | 78 | 70 | 75 | 77 | 83 | 71 | 93 | 82 | 97 | 75 | 74 | 74 | 83 | 67 |
| Expenses | 47 | 38 | 52 | 43 | 53 | 41 | 62 | 55 | 61 | 47 | 50 | 50 | 53 | 50 | 49 | 48 | 43 | 43 | 33 | 47 | 58 | 57 | 65 | 63 | 61 | 63 | 71 | 65 | 70 | 71 | 74 | 64 | 85 | 74 | 85 | 68 | 66 | 65 | 74 | 60 |
| EBITDA | 3 | 3 | 4 | 5 | 1 | 4 | 4 | 3 | 4 | 5 | 5 | 5 | 4 | 5 | 5 | 2 | 2 | 1 | 2 | 5 | 7 | 6 | 7 | 8 | 7 | 7 | 7 | 5 | 6 | 7 | 8 | 7 | 8 | 8 | 12 | 7 | 8 | 8 | 9 | 7 |
| Operating Profit % | 5 % | 6 % | 6 % | 10 % | 2 % | 6 % | 4 % | 4 % | 5 % | 9 % | 8 % | 7 % | 7 % | 7 % | 11 % | 3 % | 4 % | 2 % | 2 % | 10 % | 11 % | 9 % | 9 % | 11 % | 9 % | 9 % | 5 % | 7 % | 8 % | 8 % | 10 % | 9 % | 8 % | 10 % | 10 % | 9 % | 10 % | 11 % | 9 % | 9 % |
| Depreciation | 4 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 4 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 3 |
| Interest | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 4 |
| Profit Before Tax | 0 | 0 | 2 | 2 | -2 | 1 | 2 | 0 | -1 | 1 | 1 | 1 | -0 | 1 | -1 | -3 | -3 | -3 | -5 | 1 | 2 | 1 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 0 | 2 | 1 | 6 | 1 | 1 | 1 | 3 | 0 |
| Tax | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | -1 | 1 | -1 | -2 | -0 | -1 | 1 | -0 | 0 | 1 | 1 | -3 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | -3 | 0 |
| Net Profit | 0 | 0 | 2 | 1 | -3 | 1 | 1 | -0 | -2 | 1 | 1 | 2 | -1 | 2 | 1 | -3 | -2 | -4 | -5 | 0 | 1 | 0 | 4 | 2 | 1 | 1 | 2 | 0 | 0 | 1 | 2 | 0 | 1 | 1 | 6 | 0 | 1 | 1 | 5 | 0 |
| EPS in ₹ | 0.26 | 0.21 | 1.52 | 1.52 | -0.24 | 0.04 | 0.12 | 0.43 | -1.29 | 0.24 | 0.45 | 1.12 | -0.53 | 1.12 | 0.77 | -1.74 | -1.29 | -2.52 | -3.21 | 0.30 | 0.30 | 0.22 | 2.52 | 1.09 | 0.97 | 0.32 | 1.33 | 0.19 | 0.08 | 0.38 | 1.03 | 0.06 | 0.62 | 0.54 | 3.73 | 0.16 | 0.65 | 0.33 | 3.40 | 0.13 |
Bal Pharma
Bal Pharma
80.31
-0.77
(-0.95%)
Key Fundamentals
Market Cap
129.10 Cr
EPS
4.54
PE Ratio
17.79
Dividend Yield
1.50 %
Industry
Healthcare 52 Week High
140.95
52 Week Low
78.06
PB Ratio
1.65
Debt to Equity
1.94
Sector
Pharmaceuticals Actual
Company News
View All News
Bal Pharma Sets September 18, 2025 as Record Date for Dividend PaymentAug 12, 2025
Bal Pharma Limited's Board of Directors has fixed September 18, 2025 as the record date for dividend payment for the financial year ended March 31, 2025. The dividend payment is subject to shareholder approval at the company's 38th Annual General Meeting scheduled for September 25, 2025. The board decision was made at their meeting held on August 11, 2025.
Bal Pharma Limited's Board of Directors approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported standalone revenue from operations of ₹6,563.51 lakhs and net profit of ₹32.31 lakhs for the quarter. On a consolidated basis, revenue from operations was ₹6,587.09 lakhs with net profit of ₹20.85 lakhs. The Board scheduled the 38th Annual General Meeting for September 25, 2025, and decided to close the register of members from September 19-25, 2025. Additionally, the Board approved an Employee Stock Option Plan-2025, subject to shareholder approval at the upcoming AGM. The company's statutory auditors issued an unmodified opinion on the quarterly results.
Bal Pharma Ltd has scheduled a Board of Directors meeting for August 11, 2025, to consider several key matters. The board will review unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, and discuss convening the 38th Annual General Meeting along with book closure dates. Additionally, the meeting will address approval of a draft Employee Stock Option Plan-2025 and consider the merger of subsidiary Lifezen Healthcare Pvt Ltd with Bal Pharma Ltd. The company has implemented a trading window closure for designated persons and employees from June 1, 2025, to August 14, 2025, which extends 48 hours after the declaration of quarterly financial results.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-10.76 %
Net Income Growth
-2.70 %
Cash Flow Change
-10.92 %
ROE
-9.66 %
ROCE
-6.05 %
EBITDA Margin (Avg.)
5.91 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 164 | 211 | 233 | 260 | 261 | 238 | 240 | 261 | 313 | 320 | 336 |
| Fixed Assets | 52 | 56 | 60 | 72 | 70 | 71 | 69 | 67 | 77 | 80 | 87 |
| Current Assets | 105 | 143 | 165 | 185 | 183 | 157 | 164 | 185 | 228 | 234 | 235 |
| Capital Work in Progress | 1 | 4 | 2 | 0 | 4 | 3 | 0 | 2 | 0 | 1 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 3 |
| Other Assets | 111 | 151 | 172 | 189 | 187 | 164 | 172 | 192 | 237 | 233 | 244 |
| Total Liabilities | 164 | 211 | 233 | 260 | 261 | 238 | 240 | 261 | 313 | 320 | 336 |
| Current Liabilities | 92 | 111 | 143 | 154 | 163 | 160 | 153 | 166 | 209 | 203 | 220 |
| Non Current Liabilities | 16 | 45 | 30 | 46 | 38 | 34 | 34 | 36 | 40 | 45 | 39 |
| Total Equity | 55 | 55 | 60 | 60 | 60 | 45 | 53 | 59 | 64 | 72 | 77 |
| Reserve & Surplus | 40 | 40 | 48 | 51 | 53 | 38 | 38 | 43 | 48 | 56 | 62 |
| Share Capital | 13 | 13 | 14 | 14 | 14 | 14 | 15 | 15 | 16 | 16 | 16 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 2 | -1 | -8 | 1 | -0 | -2 | 0 | 0 | 0 | 3 | -2 |
| Investing Activities | -5 | -14 | -8 | -4 | -8 | -5 | -6 | -10 | -22 | -19 | -15 |
| Operating Activities | 15 | -19 | 6 | 1 | 8 | 23 | 22 | 27 | -2 | 23 | 20 |
| Financing Activities | -7 | 32 | -6 | 4 | 0 | -20 | -17 | -17 | 24 | -1 | -8 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Apr 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 44.98 % | 44.84 % | 46.87 % | 49.57 % | 49.57 % | 52.00 % | 52.00 % | 52.00 % | 51.61 % | 51.61 % | 51.61 % | 51.61 % | 51.23 % | 51.23 % | 51.23 % | 50.86 % | 50.86 % | 50.86 % | 50.86 % | 50.86 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.13 % | 0.13 % | 0.13 % | 0.14 % | 0.14 % | 0.15 % | 0.22 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 37.31 % | 38.37 % | 35.73 % | 32.97 % | 32.88 % | 31.30 % | 31.45 % | 31.49 % | 32.13 % | 32.07 % | 32.00 % | 32.19 % | 32.63 % | 32.15 % | 32.36 % | 33.15 % | 32.57 % | 32.49 % | 32.41 % | 32.97 % |
| Others | 17.72 % | 16.79 % | 17.40 % | 17.46 % | 17.55 % | 16.70 % | 16.55 % | 16.52 % | 16.26 % | 16.32 % | 16.40 % | 16.20 % | 16.13 % | 16.49 % | 16.28 % | 15.86 % | 16.43 % | 16.51 % | 16.58 % | 15.94 % |
| No of Share Holders | 12,648 | 16,531 | 16,319 | 16,049 | 16,223 | 16,223 | 16,317 | 16,170 | 16,466 | 16,029 | 15,869 | 15,529 | 15,060 | 14,772 | 15,014 | 16,007 | 15,667 | 15,723 | 15,826 | 15,774 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1 | 1 | 1 | 0.00 | 1 | 1 | 1 | 1.2 | 1.2 |
| Dividend Yield (%) | 0.00 | 1.3 | 1.43 | 3.13 | 0.00 | 0.93 | 1.55 | 1.1 | 1.43 | 1.49 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 Sept 2021 |  Dividend | ₹ 1.00 /share | 16 Sept 2021 | 97.65 | 104.40 |
| 15 Sept 2022 | Dividend | ₹ 1.00 /share | 13 Sept 2022 | 99.25 | 97.90 |
| 19 Sept 2023 | Dividend | ₹ 1.00 /share | 18 Sept 2023 | 86.10 | 95.17 |
| 21 Dec 2023 |  Extraordinary General Meeting | NA | 21 Dec 2023 | 108.70 | 97.65 |
| 19 Sept 2024 | Dividend | ₹ 1.20 /share | 17 Sept 2024 | 100.25 | 131.80 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 112.38 | 128.40 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 124.70 | 114.81 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 111.75 | 97.65 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 101.85 | 95.60 |
| 11 Aug 2025 | Quarterly Result Announcement | NA | 11 Aug 2025 | 97.73 | 94.22 |
| 18 Sept 2025 | Dividend | ₹ 1.20 /share | 18 Sept 2025 | 95.60 | 89.39 |
| 25 Sept 2025 | Annual General Meeting | NA | 25 Sept 2025 | 94.22 | 85.40 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Oct 06, 2025
Oct 06, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2025
Sep 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Reg. 34 (1) Annual Report.Sep 02, 2025
Sep 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Corporate Action-Fixes Record Date For Dividend.Aug 12, 2025
Aug 12, 2025Unaudited Financial For The Quarter Ended 30.06.2025.Aug 11, 2025
Aug 11, 2025Board Meeting Outcome for Outcome Of The Board MeetingAug 11, 2025
Aug 11, 2025Board Meeting Intimation for Inter Alia Take On Record And Approve The Unaudited Financial Results For The Quarter Ended 30.06.2025.Jul 29, 2025
Jul 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 10, 2025
Jul 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 03, 2025
Jul 03, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 02, 2025
Jul 02, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 20, 2025
Jun 20, 2025Intimation To The Physical Shareholders For Updating KYC.Jun 16, 2025
Jun 16, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 16, 2025
Jun 16, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Jun 02, 2025Board Meeting Outcome for Outcome Of The Board Meeting-Audited Financial Results And Recommendation Of DividendMay 29, 2025
May 29, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorMay 16, 2025
May 16, 2025Board Meeting Intimation for Approval Of Audited Financial Results Of The Company And Recommendation Of Dividend Is Any For The Financial Year Ended 31.03.2025.May 15, 2025
May 15, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 05, 2025
May 05, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2025
Apr 24, 2025Update On Application Filed For Reclassification Of PromotersApr 18, 2025
Apr 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementMar 28, 2025
Mar 28, 2025Closure of Trading WindowMar 25, 2025
Mar 25, 2025Withdrawal Of Promoter Reclassification Request.Mar 20, 2025
Mar 20, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 18, 2025
Feb 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Feb 17, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Standalone And Consolidated Financial Results For The Quarter Ended 31.12.2024.Feb 13, 2025
Feb 13, 2025Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30.09.2024.Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Outcome Of The Board MeetingFeb 13, 2025
Feb 13, 2025Board Meeting Intimation for Board Meeting IntimationJan 24, 2025
Jan 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Jan 06, 2025Change In The Name Of RTAJan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesDec 03, 2024
Dec 03, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 28, 2024
Nov 28, 2024Disclosure Regarding Reclassification Of Promoter GroupNov 22, 2024
Nov 22, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Nov 15, 2024Board Meeting Outcome for Un-Audited Financial Results For The Quarter & Half Year Ended 30.09.2024.Nov 14, 2024
Nov 14, 2024Un-Audited Financial Results For The Quarter Ended 30.09.2024.Nov 14, 2024
Nov 14, 2024Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2024Nov 05, 2024
Nov 05, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 18, 2024
Oct 18, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 15, 2024
Oct 15, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 04, 2024
Oct 04, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 01, 2024
Oct 01, 2024Technical Indicators
RSI(14)
Neutral 32.14
ATR(14)
Less Volatile 2.76
STOCH(9,6)
Oversold 10.54
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.05
ADX(14)
Weak Trend 14.76
UO(9)
Bearish 31.41
ROC(12)
Downtrend And Accelerating -3.15
WillR(14)
Oversold -96.99
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
